Skip to content

On no man's land: Subjective experiences during unresponsive and responsive sedative states induced by four different anesthetic agents.

Linda Radek, Lauri Koskinen, Nils Sandman, Lauri Laaksonen, Roosa E Kallionpää, Annalotta Scheinin, Ville Rajala, Anu Maksimow, Timo Laitio, Antti Revonsuo, Harry Scheinin, Katja Valli

Consciousness and Cognition November 1, 2021 DOI: 10.1016/j.concog.2021.103239 (opens in new tab)

Study at a glance

AI-extracted from the abstract
Characteristics Randomized controlled trial Peer reviewed
Sample size 140
Population Healthy male participants
Interventions Dexmedetomidine Propofol Sevoflurane S-ketamine
Duration One-hour administration
Topics Dreaming Ketamine
Keywords Anesthesia Awareness Consciousness Dexmedetomidine Propofol Responsiveness Sevoflurane Subjective experiences
Key findings Subjective experiences during sedation are common, with 46.9% of arousable participants reporting experiences, and the type of anesthetic may have minor effects on prevalence and complexity.

Abstract

To understand how anesthetics with different molecular mechanisms affect consciousness, we explored subjective experiences recalled after responsive and unresponsive sedation induced with equisedative doses of dexmedetomidine, propofol, sevoflurane, and S-ketamine in healthy male participants (N = 140). The anesthetics were administered in experimental setting using target-controlled infusion or vapouriser for one hour. Interviews conducted after anesthetic administration revealed that 46.9% (n = 46) of arousable participants (n = 98) reported experiences, most frequently dreaming or memory incorporation of the setting. Participants receiving dexmedetomidine reported experiences most often while S-ketamine induced the most multimodal experiences. Responsiveness at the end of anesthetic administration did not affect the prevalence or content of reported experiences. These results demonstrate that subjective experiences during responsive and unresponsive sedation are common and anesthetic agents with different molecular mechanisms of action may have different effects on the prevalence and complexity of the experiences, albeit in the present sample the differences between drugs were minute.

Comparable studies

Other randomized controlled trials on dreaming, most cited first.

Study Year Design Participants
Efficacy of a Cognitive‐Behavioral Treatment for Insomnia and Nightmares in Afghanistan and Iraq Veterans With PTSD Combat veterans of Operation Enduring Freedom and/or Operation Iraqi Freedom (mean age... 2013 Randomized controlled trial n = 40
Lucid Dreaming Treatment for Nightmares: A Pilot Study Chronic nightmare sufferers 2006 Randomized controlled trial n = 23
Testing the involvement of the prefrontal cortex in lucid dreaming: A tDCS study Participants spending three consecutive nights in a sleep laboratory 2013 Randomized controlled trial n = 19
Pre-sleep treatment with galantamine stimulates lucid dreaming: A double-blind, placebo-controlled, crossover study Adults with high dream recall and an interest in lucid dreaming 2018 Randomized crossover trial n = 121
Studies with lucid dreaming as add-on therapy to Gestalt therapy Adults with nightmares (ICD-10: F51.5) at least twice a week 2015 Randomized controlled trial n = 32

Citations in the library

Explore topics